Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy

Eitemau Tebyg

• Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options
  gan: Çetin, Güven, et al.
  Cyhoeddwyd: (2014)
• Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options
  gan: Güven Çetin, et al.
  Cyhoeddwyd: (2014-12-01)
• The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply)
  gan: Visani, Giuseppe, et al.
  Cyhoeddwyd: (2011)
• Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
  gan: Eşkazan, Ahmet Emre, et al.
  Cyhoeddwyd: (2013)
• Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
  gan: Ahmet Emre Eşkazan, et al.
  Cyhoeddwyd: (2013-06-01)